Granules India Q2 net up 40 per cent at Rs 31 crore

Firm's total income from operations up 19% at Rs 366 cr; net profit margin improves by 128 basis points to 8.5%

Hyderabad-based pharmaceutical company Granules India Limited has reported a 40 per cent jump in net profit at Rs 31 crore for the quarter ended September 2015 on the back of increased revenues and profit margins. The total income from operations grew 19.12 per cent at Rs 366.44 crore as compared with Rs 307.63 crore in the corresponding quarter last year.

The EBITDA margins were up 33 per cent while the net profit margin improved by 128 basis points to 8.5 per cent from 7.2 per cent in the corresponding previous quarter, according to the company. Regulated markets accounted for 55 per cent of the company's total sales revenues during the period.

"Our continuous endeavor to improve operational efficiency and process innovation has resulted yet another strong quarter for us. We are happy to see growth in revenue and profit along with improved margin profiles compared to the same quarter previous year," C Krishna Prasad, chairman and managing director of Granules India said.